Renal Business Today - Polycystic Kidney Disease (PKD)

Nephrologists Report Unmet Need for Therapies Targeted at PKD

EXTON, Penn.—A recent survey of 100 U.S. nephrologists reported that there is a need for new therapies targeted at Polycystic Kidney Disease (PKD), a genetic disorder characterized by the growth of numerous cysts in the kidneys. ...More

February 27, 2012

Posted in News, Clinical & Pharma

PKD Foundation Names New President, CEO

KANSAS CITY, Mo.—The PKD Foundation has announced that Gary Godsey will be its new president and chief executive officer, effective Nov. 28. ...More

November 2, 2011

Posted in News, Business

Single Gene Controls Growth of Polycystic Disease

NEW HAVEN, Conn.—A single gene is central in the development of several forms of polycystic kidney and liver disease, Yale School of Medicine researchers reported in the June 19 issue of Nature Genetics. ...More

June 21, 2011

Posted in News, Clinical & Pharma

Aurora A Gene May Contribute to PKD

PHILADELPHIA—The Aurora A kinase may contribute to polycystic kidney disease (PKD) by inactivating a key calcium channel in kidney cells, according to a study in the June 13 issue of The Journal of Cell Biology. ...More

June 14, 2011

Posted in News, Clinical & Pharma

Foundation Honors Doctors Dedicated to Conquering PKD

The PKD Foundation, which accelerates development of treatments for PKD (polycystic kidney disease) patients, is again partnering with the International Society of Nephrology to honor two top doctors in the PKD field as recipients of the 2011 Lillian Jean Kaplan ...More

February 11, 2011

Posted in News, Clinical & Pharma

Intellikine, PKD Foundation Collaborate on New Treatments

LA JOLLA, Calif.—Intellikine and the PKD Foundation have announced a collaboration to investigate novel, orally available small molecule kinase inhibitors of the TORC1 and TORC2 complexes as a potential treatment for patients with polycystic kidney disease (PKD). ...More

February 10, 2011

Posted in News

Diabetes Drug May Stop PKD Cysts

INDIANAPOLIS—Researchers report that a drug commonly used to treat diabetes may also retard the growth of fluid-filled cysts of the most common genetic disorder, polycystic kidney disease. ...More

November 12, 2010

Posted in News, Clinical & Pharma

Experimental PKD Drug Decreases Size, Number of Cysts

BOSTON—Researchers were able to block the formation of fluid-filled cysts using an experimental drug to treat polycystic kidney disease (PKD) in a mouse model, according to a study published in the Sept. 13 issue of the Journal of Clinical Investigation. ...More

September 14, 2010

Posted in News, Clinical & Pharma

Rapamycin A Potential New Treatment for ADPKD

The drug rapamycin may be a potential treatment for the inherited kidney disease, autosomal-dominant polycystic kidney disease (ADPKD), according to new research from the University of California, Santa Barbara that was published in the Journal of the American Society of ...More

January 26, 2010

Posted in News, Business, Clinical & Pharma

Epilepsy Drug Shows Promise in Treating PKD

NEW HAVEN, Conn.—An anti-convulsant drug commonly used to treat epilepsy reduces cysts in mice that are associated with polycystic kidney disease (PKD), a difficult to treat ailment that afflicts 600,000 people in the United States, according to Yale University researchers. ...More

December 7, 2009

Posted in News, Clinical & Pharma

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Polycystic Kidney Disease (PKD)

Mobile Health Snaps

Galleries

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail